Evidence that the protein components of bovine erythrocyte green heme binding protein and flavin reductase are identical by Quandt, Kim S. et al.
Vol. 178, No. 1, 1991 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
July 15, 1991 Pages 315-321 
EVIDENCE THAT THE PROTEIN COMPONENTS OF BOVINE ERYTHROCYTE 
GREEN HEME BINDING PROTEIN AND FLAVIN REDUCTASE ARE IDENTICAL 
Rim S. Quandt, Feng Xu, Ping Chen, and Donald E. Hultquist* 
Department of Biological Chemistry 
Medical School 
The University of Michigan 
Ann Arbor, Michigan 48 109-0606 
Received June 3, 1991 
SUMMARY: Bovine erythrocyte green heme binding protein and bovine erythrocyte flavin 
reductase have been isolated in highly purified forms and subjected to amino acid analysis and N- 
terminal amino acid sequence analysis. The two proteins possess imilar amino acid compositions 
and identical N-terminal amino acid sequences. Moreover, the two proteins are immunochemically 
cross-reactive and are indistinguishable when compared by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis and by double diffusion technique. This study provides evidence that the 
protein components of bovine erythrocyte green heme binding protein and flavin reductase are 
identical. C 1991 Academic Press, Inc. 
Green heme binding protein, GHBP, is a water-soluble protein which has been isolated 
from hemolysates of bovine and human erythrocytes (l-3). The unique spectral properties of the 
hemeprotein arise from its highly conjugated, polar, and unstable prosthetic group, which is 
distinguishable from all known hemes (4,5). This hemeprotein is remarkable in that its ferrous 
form undergoes extremely rapid autoxidation, and both its ferrous and ferric forms readily react 
with peroxides to yield completely colorless products (6). 
Flavin reductase, FR, is a protein which has been isolated from hemolysates of human and 
animal erythrocytes (7- 11). This protein has variously been referred to as an emtiucfle NADPH 
dehydrogenase, diaphorase, and metbemoglobin reduw The reductase activity ascribed to this ,I, 
protein was first reported 60 years ago as a methemoglobin reductase activity of erythrocytes in the 
presence of methylene blue (12- 14). Subsequently, stimulations of methemoglobin reduction by 
dyes and by flavin have been observed in hemolysates and reconstituted systems (15). Evidence 
suggests that the reductase catalyzes the transfer of electrons from NADPH to the dye or flavin, 
and that the resulting reduced form of the dye or flavin then chemically reduces methemoglobin 
(12,16,17). This stimulation constitutes the basis for the therapeutic use of methylene blue 
( 13,14,18) and flavin ( 19,20) in the treatment of congenital and toxic methemoglobinemia. 
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ABBREVIATIONS USED: GHBP, green heme binding protein; FR, flavin reductase; SDS-PAGE, 
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However, under normal in viva conditions, the reductase plays a very minor role in reducing 
methemoglobin (21). 
In this paper we report the N-terminal amino acid sequences and the amino acid 
compositions of bovine erythrocyte green heme binding protein and flavin reductase. These 
analyses, together with electrophoretic and immunochemical studies, provide evidence that the 
protein components of these two proteins are identical. Some of these data have been presented 
previously in abstract form (22,23). 
MATERIALS AND METHODS 
Materials. Freund’s complete and incomplete adjuvants were obtained from DIFCO 
Laboratories. Electrophoresis-purity reagents and silver stain low range molecular weight protein 
standards (phosphorylase b, bovine serum albumin, ovalbumin, carbonic anhydrase, soybean 
trypsin inhibitor and lysozyme) were obtained from Bio-Rad. For immunoblotting, prestained low 
molecular weight protein standards (ovalbumin, carbonic anhydrase, l+lactoglobulin, lysozyme, 
bovine trypsin inhibitor, A and B chains of insulin) were obtained from Bethesda Research 
Laboratories. Nitrocellulose was obtained from Schleicher & Schuell and nitro blue tetrazolium, 
5-bromo-4-chloro-3-indoyl phosphate, and alkaline phosphatase-conjugated anti-rabbit IgG 
(developed in goat) from Sigma. Lysyl endopeptidase (Lys-C) of achromobacterlytjcus M497-1 
was obtained from Wako Chemicals USA. 
Generalmethods. Spectrophotometry was performed on a Kontron Uvikon 80. Protein 
was quantitated by the Pierce BCA method using bovine serum albumin as standard (24). 
Extinction coefficients were determined for pure FR at 268 nm, and for pure GHBP at 416 nm, 
using protein contents obtained from the BCA method. Thereafter, FR and GHBP concentrations 
were calculated using absorbance at 268 mn or 4 16 nm. SDS-PAGE was performed with a Bio- 
Rad Mini-Protean II Dual Slab Cell using a discontinuous buffer system (25) and gels were stained 
with silver (26). For immunoblotting, proteins were electro-transferred from gel to nitrocellulose 
(27) using a Bio-Rad Trans-Blot Cell. tmmunoblotting was performed using antiserum to bovine 
erythrocyte GHBP and alkaline phosphatase-conjugated anti-rabbit IS;, and color was developed 
using 5-bromo-4-chloro-3-indoyl phosphate and nitro blue tetmzolium. Two-dimensional double 
diffusion was allowed to proceed for 12 to 24 h in gels containing 1% purified agar and 0.85% 
NaCl buffered with 0.1 M phosphate, pH 7.2 (28). 
PuMcatJon of GHBPand FR. Bovine erythrocyte GHBP (form I) was purified according 
to the previously published procedure (3). 
Bovine etythrocyte FR was purified by a modification of the chromatographic procedures 
used by Yubisui et al. to purify flavin reductase from human erythrocytes (11). The FR which had 
been purified by chromatography on DEAE-cellulose and Bio-Gel P-60 and then 
re-chromatographed on Bio-Gel P-60 was found by SDS-PAGE to be of high purity and was 
used without further purification. 
Aarjsem production. Antisera to bovine erythrocyte GHBP were raised by immunization 
of young adult male New Zealand White rabbits. Each animal was given eight to twelve 
intradermal injections on the back, for a total of 50 pg of purified GHBP in 1 ml of emulsified 
Freund’s complete adjuvant. During the second week, booster injections totaling 50 pg of GHBP 
in Freund’s complete adjuvant were. again given intradermally. During the fourth week, booster 
injections totaling 50 pg of GHBP in Freund’s incomplete adjuvant were given intramuscularly and 
subcutaneously. A week after the last booster injection, and every two weeks thereafter, blood 
was collected from ear veins, allowed to clot, centrifuged at 9000 x g for 10 mitt, and the sem 
decanted. Specificity of the antisera was tested by immumoblotting. Antisera were stored at 
-20°C. 
Amino acidan&sJs. The protein sample underwent gas phase hydrolysis in 6 N HCl at 
110” C for 24 h. Amino acid analyses were performed by Fulvio Pet-h& Eric Malek, and Philip 
Andrews of the Protein Structure Facility ofthe University ofMichigan using an Applied 
Biosystems Instrument 420H Amino Acid Analyzer and standard operating conditions. Tryptophan 
content of FR was quantitated by a magnetic circular dichroism (MCD) method (29) using a Jasco 
J-40C spectropolarimeter equipped with an electromagnetic capable of genemting a 15 kG magnetic 
field and interfaced with a Nova HI computer and a Tracer 15OON signal analyzer. 
Preparation aadsepamtion ofpeptides derived from GDP wJ~JI Lys-C. Urea-denatured 
GHBP (12.2 pg) WZIS digested by Lys-C (0.1 pg) for four h at 37°C. Another aliquot of Lys-C 
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was then added and the incubation continued for an additional four h. The resulting peptides were 
sepamted by reverse-phase HPLC, using an Aquapore RP-300 column and an aqueous 
trifluoroacetic acitiacetonitrile gmdient in a Applied Siosystems Instrument 130A Separation 
System. Peptide peak fractions were collected manually into microtubes. Selected peptides were 
subjected to amino acid sequencing. 
Amino acid sequencing. Amino acid sequencing was performed on an Applied Biosystem 
470A Protein Sequencer interfaced with an Applied Biosystem 120A Analyzer and on an Applied 
Biosystems 473A Protein Sequencer. Prior to N-terminal amino acid sequencing, GHBP was 
chemically reduced and any Cys residues were alkylated with vinylpyridme. The sequencing was 
performed by Rim Mountjoy, Sari Vlahakis, and Philip Andrews of the Protein Structure Facility 
of the University of Michigan. 
RESULTS 
Bovine erythrocyte green heme binding protein and tlavin reductase migrate identically on 
SDS-PAGE, as shown by the silver-stained gel in Fig. 1A. The two proteins are 
immunochemically cross-reactive, as shown in the immunoblot in Fig. lB, which utilized rabbit 
antiserum elicited against purified bovine erythrocyte GHBP. 
The two proteins form lines of identity upon agar-gel double diffision using the anti- 
GHBP serum, as shown in Fig. 2. The polyclonal antibodies precipitate only one band in bovine 
hemolysate and do not react with bovine hemoglobin. 
The results of the amino acid analyses of bovine erythrocyte GHBP and FR are reported in 
Table I, expressed as the number of residues for a protein of 23,000 daltons. Tryptophan content 
of FR was determined by MCD to be 1.4 mole Trp/ mole of protein. 
The results of N-terminal amino acid sequencing of bovine erythrocyte GHBP and FR are 










FIG. 1. Comparison of GHBP and FR. A. SDS-PAGE. Proteins were electrophorectically 
separated on a 15% SDS-polyacrylamide gel and then silver stained. Lane 1, protein molecular 
weight standards, sizes as indicated; lane 2, purified bovine erythrocyte GHBP (50 ng); lane 3, 
purified bovine erythrocyte FR (50 ng). B. Immunoblot. Proteins were electrophoretically 
separated on a 15% SDS-polyacrylamide gel, electrotransferred to nittocellulose, and then blotted 
using antiserum against bovine erythrocyte GHBP. Lane 1, prestnined protein molecular weight 
standards, sizes as indicated; lane 2, purified bovine erythrocyte GHBP (20 ng); lane 3, purified 
bovine erythrocyte FR (20 ng); lane 4, bovine hemolysate (20 pg total protein). 
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FIG. 2. Comparison of GHBP and FR by agar-gel double diffusion. The central well contained 
ammonium sulfate-precipitate-d antiserum from rabbit which had been injected with purified bovine 
erythrocyte GHBP. Wells land 3, purified bovine erythrocyte FR (4 pg); wells 2 and 5, purified 
bovine erythrocyte GHBP (4 pg); well 4, bovine hemoglobin (4 pg); well 6, bovine hemolysate 
( 1.5 mg total protein). 
positions of uncertainties. The sequencing of FR was interpretable for 36 cycles with one position 
of uncertainty. 
The results of amino acid sequencing of peptides derived from GIIBP by Lys-C digestion 
are presented in Table III. Of the 24 peaks resolved on HPLC, three peptides were subjected to 
amino acid sequencing: #7, which eluted from the HPLC at 49.2 min; #l 1, which eluted at 58.0 
Table I 
Amino Acid Analysis of Bovine Etythrocyte GHBP and FR 
Amino Acid GHBPa FRb 
Asx 21.5 15.9 
Thr 18.3 20.1 
Ser 11.8 10.1 
Glx 15.7 16.1 
Pro 15.9 16.8c 
GUY 21.3 20.8 
Ala 20.0 20.8 
Val 24.5 26.9 
CYS 
Met i-3 2.2 
Be 5.4 L u 19 1 226.4 
Tyr 5.8 419 
Phe 
LYS it; E 
His 10:3 12:2 
Arg 8.4 8.7 
Trpd -- 1.4 
a Average of three analyses. 
b Average of two analyses. 
‘Pro content in FR was determined in a single analysis. 
d Trp content of FR was determined by the MCD method. 
Trp content of GHBP was not determined by this method 
since it can not be applied to hemeproteins. 
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Table II 
Amino-Terminal Sequences of E@rocyte GI-IBP and FR 
1 5 10 15 
Bovine GHBF Val-Val-Lys-Lys- Ile -Ala-Leu-Phe-Gly-Ala-Thr-Gly-Asn-Thr-Gly-Leu-Thr- ?b - 
Bovine FRC Val-Val-Lys-Lys- Ile -Ala-Leu-Phe-Gly-Ala-Thr-Gly-Asn-Thr-Gly-Leu-T’hr-Thr- 
Bullfrog FRd Ala-Pro-Lys-Asn- Ile-Val-Leu-Phe-Gly-Ala-Thr-Gly-Met-Thr-Gly-Gln-V~-~r- 
20 25 30 35 36 
Bovine GHBP Leu-Ala -Gin-Ala-Val-Gln-Ala-Gly-Tyr-Glu-Val- ?b -Val- ?b- Val-Arg-Asp-Pro - - 
Bovine FR Leu-Ala -Gln-Ala-Val-Gln-Ala-Gly-Tyr-Glu-Val-Thr-Val-Leu- ?b-Arg-Asp-Pro - - 
Bullfrog FR Leu-Gly -Gin-Ala-Leu-Glu - - 
a GHBP was chemically reduced and any Cys alkylatcd with vinylpyridine prior to sequencing. 
Repetitive yields of sequencing were 86% to 94%. 
b Amino acid was not identified. 
‘Repetitive yields of sequencing were 93% to 97%. 
d From reference 3 1. 
min; and #2 1, which eluted at 73.1 min. Peptide #7 was sequenced for its full length of 17 
residues, with one position of uncertainty. Peptides #1 1 was sequenced for 24 cycles, with one 
position of uncertainty. Peptides #2 1 was analyzed for five cycles before sequencing was 
terminated, when it became apparent that this peptide was derived from the N-terminal region that 
had already been sequenced. 
DKCUSSION 
Green heme binding protein and flavin reductase possess identical N-terminal amino acid 
sequences and they have very similar amino acid compositions. Moreover, these two bovine 
erythrocyte proteins are immunochemically cross-reactive and are indistinguishable by SDS-PAGE 
Table III 
Partial Sequences of Peptidcs Derived from a Lys-C Digest of Bovine Erythrocyte GHBP 
Pcptide #7 a 
Val-Pro- ?b -Arg-Leu-Gln-Asp-Val-Thr-Asp-AspHis- Ile-Arg-Met-His-Lys 
Peptide # 11’ 
Tyr-Val-Ala- Val-Met-Pro- ?b -His- Ile-Glu-Asp-His-Pro-Leu-Thr-Gly- Ala-Tyr-Thr-Val- 
Thr-Leu-Asp-Gly - - 
Peptide #2 1 d 
Ile-Ala-Leu-Phe-Gly - - 
a Eluted from the HPLC column at 49.2 min. Repetitive yields of sequencing were 87% to 93%. 
bAmino acid was not identified. 
‘Eluted from the HPLC column at 58.0 min. Repetitive yields of sequencing were 86% to 92%. 
d Eluted from the HPLC column at 73.1 min. 
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and double diffusion. These results indicate that the protein components of bovine erythrocyte 
GHBP and bovine erythrocyte FR are identical. Final demonstration of identity must await the 
determination of the complete amino acid sequence of both proteins. 
The N-terminal sequence does not have an initial methionine residue, suggesting that 
post-translational processing of the protein has occurred. The N-terminal region possesses three 
cationic charges, the amino-terminal Val, Lys-3 and Lys-4, whereas the adjacent stretch of 23 
residues is completely hydrophobic. There is an interesting tandem repeating sequence, 
Gly-X-Thr, found between residues Gly-9 and Thr- 17. 
Inspection of the sequence of peptide #21 derived from GHBP by Lys-C digestion reveals 
that this peptide is probably derived from the N-terminal region as a result of cleavage on the 
carboxyl side of Lys4 to yield a peptide starting with Ile-5. Peptides #7 and #l 1 are internal 
sequences. In contrast to the N-terminal sequence, peptide #7 is very hydrophilic, possessing six 
charged amino acids and three polar amino acids in this stretch of 17 residues. 
This bovine erythrocyte protein shows similarity to the structuml features which have 
reported for FR from human (30) and bullfrog (3 1) erythrocytes. Bullfrog FR has an analogous 
cationic N-terminal region followed by a hydrophobic region, as shown in Table II. Comparison 
of the N-terminal sequences of bovine and bullfrog FR shows that, of the first 24 residues 58% are 
identical and 20% represent a conservative change. The amino acid composition of the 25 
N-terminal residues of human FR has been reported and shows a striking similarity to bovine FR. 
In the N-terminal region, each protein has 12 hydrophobic residues (Ala, Val, Leu, and Ile), 
3 polar residues (Asn and Gln), 4 Thr residues, 3 Gly residues, 2 Lys residues, and one Phe 
residue. Likewise, the amino acid compositions of intact FR from bovine, human, and bullfrog 
are very similar. 
Other than the homology to flavin reductases of other species, no significant homology was 
detected upon searching the proteins in the data base of the National Biomedical Research 
Foundation. Among the proteins sequences which showed no homology were catalase, 
cytochrome b,, cytochrome P-450, glutathione-S-transfemse, glutathione peroxidase, hemoglobin, 
myleoperoxidase, myoglobin, tryptophan ox&se, and tryptophan peroxidase. 
The apparent identity of the protein components of GHBP and FR is surprising in light of 
the fact that the spectral and catalytic properties of these proteins have been reported over many 
decades to be markedly different. Our findings again raise the questions as to the nature of the 
chromophore or cofactor which is associated with this protein in tivo and as to the biological 
significance of this protein. Future structural and catalytic studies will attempt to establish whether 
the physiological significance of the protein lies in its classical but very low-level reductase 
activity, in its rapid reactions with oxygen and peroxide, or, as suggested recently (23) in its ability 
to bind protohemin. 
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